| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Actinium Pharmaceuticals, Inc. (ATNM) has 1 insider with recent SEC Form 4 filings, including 11 buys and 0 sells. ATNM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 184.5K | $241.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 10, 2018 | O'Loughlin Steve | Principal Financial Officer | Buy | 10,000 | $0.44 | $4,350.00 | +39.2% | |
| Dec 10, 2018 | Seth Sandesh | Chairman &CEO | Buy | 10,000 | $0.44 | $4,372.00 | +7.0% | |
| Nov 19, 2018 | Ludwig Dale L. | Chief Scientific Officer | Buy | 10,000 | $0.45 | $4,499.00 | New | |
| Jul 17, 2018 | Seth Sandesh | CEO | Buy | 10,000 | $0.79 | $7,900.00 | +7.5% | |
| Jun 15, 2018 | O'Loughlin Steve | Principal Financial Officer | Buy | 12,000 | $0.50 | $6,000.00 | +88.9% | |
| Apr 19, 2018 | Seth Sandesh | Chairman &CEO | Buy | 5,000 | $0.38 | $1,900.00 | +3.9% | |
| Feb 28, 2018 | Shetty Ajit | Director | Buy | 22,730 | $0.43 | $9,773.90 | New | |
| Aug 2, 2017 | Seth Sandesh | Chairman &CEO | Buy | 33,333 | $0.75 | $24,999.75 | +78.4% | |
| Aug 2, 2017 | Ray Nitya G. | Executive Vice President | Buy | 10,000 | $0.75 | $7,500.00 | New | |
| Jun 15, 2017 | Seth Sandesh | Chairman And CEO | Buy | 7,500 | $1.16 | $8,725.00 | +10.3% |